Scheme 16.
Most recent adamantane derivatives with anti-HSV 1 properties. Given in parentheses is the EC50 (in μg/mL) as determined by plaque-reduction assay using Vero cells.
Most recent adamantane derivatives with anti-HSV 1 properties. Given in parentheses is the EC50 (in μg/mL) as determined by plaque-reduction assay using Vero cells.